Armistice Capital can now sell its registered shares at any time, creating immediate selling pressure on a micro-cap with a going concern warning. Traders should watch for a rapid price decline as the fund monetizes its position, with the potential for a complete washout given the extreme dilution relative to float. The amplifier verdict on this shelf-becoming-effective combo supports a bearish bias despite the stock's history of erratic spikes.
Price Chart
Executive Summary
Autonomix Medical's S-3 shelf registration (File No. 333-298774) became effective on September 15, 2026, enabling the resale of 1,071,826 shares held by Armistice Capital Master Fund. This converts a pending dilution overhang into an active risk, as the fund can now sell into the market at any time, with registered shares representing ~58.6% of the current float on an $8M market cap company with a going concern opinion. The cross-filing actuarial verdict confirms this combo (IPO context + shelf context) is an amplifier, supporting a bearish read despite the stock's extreme historical volatility.
Key Facts
- S-3 shelf registration (333-298774) became effective September 15, 2026.
- Registration covers 1,071,826 shares for resale by Armistice Capital Master Fund, issued as Series E warrants at $6.25/share.
- Company received $4.9M from warrant exercise but gets no proceeds from this resale registration.
- Registered shares represent ~58.6% dilution relative to 1,828,505 shares outstanding.
- Company has a going concern opinion and market cap of ~$8M.
- Cross-filing actuarial verdict: effect-ipo-context + effect-shelf-context is an AMPLIFIER (PMI=7.29, q=0.000, n=321).
Financial Impact
Up to ~58.6% potential dilution from 1,071,826 registered shares on an ~$8M market cap company
Risk Factors
- Immediate selling pressure from Armistice Capital resale
- Going concern opinion raises risk of equity wipeout
- Extreme dilution (~58.6% of outstanding shares) on micro-cap float
- No company proceeds from this resale registration
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| EFFECT Filing (Primary) | 9999999995-26-002973 |
| Document: 9999999995-26-002973-index.html | 9999999995-26-002973 |
| Document: 9999999995-26-002973.txt | 9999999995-26-002973 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 13, 2026 13d ago | 3 | $3.01 | awaiting T+20 | — | $2.11 (−29.90%) |
Oct 2, 2026 25d ago | Press Release | $3.78 | awaiting T+20 | — | $2.11 (−44.18%) |
Sep 16, 2026 5w ago | 8-K | $4.12 $3.01 | ▼ −26.94% | ▼ −30.12% | $2.11 (−48.79%) |
Sep 16, 2026 5w ago | EFFECT | $4.12 $3.01 | ▲ +26.94% | ▲ +30.12% | $2.11 (+48.79%) |
Sep 11, 2026 6w ago | 424B5 | $4.33 $3.10 | ▲ +28.41% | ▲ +30.67% | $2.11 (+51.27%) |
Sep 4, 2026 7w ago | S-3 | $4.58 $3.47 | ▲ +24.24% | ▲ +25.95% | $2.11 (+53.93%) |
Aug 26, 2026 8w ago | 8-K | $5.63 $4.07 | ▼ −27.71% | ▼ −27.20% | $2.11 (−62.52%) |
Aug 5, 2026 11w ago | EFFECT | $12.10 $4.50 | ▼ −62.81% | ▼ −62.21% | $2.11 (−82.56%) |
Jul 28, 2026 13w ago | 8-K | $2.75 $7.19 | ▲ +161.45% | ▲ +158.07% | $2.11 (−23.27%) |
Jul 15, 2026 14w ago | 8-K | $4.92 $6.86 | ▼ −39.43% | ▼ −35.81% | $2.11 (+57.11%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers